Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

High Throughput Natural Product Discovery

Published: Monday, January 28, 2013
Last Updated: Sunday, January 27, 2013
Bookmark and Share
A technical article from Genevac details how its HT-24 centrifugal evaporation system can find and isolate novel flavour ingredients from nature.

Natural product derived discovery of novel flavour molecules is a highly complex process. Natural product sources yield complex extracts containing many components, which often do not lend themselves to processing and analysis.

Conventionally, many steps of fractionation and evaluation are necessary until a compound is obtained from natural sources at the purity required for structural analysis.

In the article a fractionation process using a Sepbox® Preparative HPLC - SPE system and a Genevac® HT-24 centrifugal evaporator is described.

The Sepbox enables two dimensional, preparative scale fractionation of natural products using high performance liquid chromatography - solid phase extraction (HPLC-SPE).

In sequential HPLC-SPE / HPLC-SPE steps individual components are isolated from complex mixtures. Each separation run produced 320 samples of approximately 45ml volume.

A Genevac HT-24 Evaporator was chosen to dry the samples because of its high sample capacity, unique technology that eliminates cross contamination due to sample bumping and automated monitoring of temperature and pressure to prevent sample degradation.

Able to evaporate 192 sample vials simultaneously the HT-24 took just two days to dry all the fractions ready for further liquid handling and testing.

Compact in design and offering a very high capacity for a wide range of sample formats including microplates, tubes, vials, fraction collector racks and Genevac’s hybrid HPLC blocks the HT-24 offers the versatility and productivity to assist chemists in high-throughput environments.

The high-throughput design of the HT-24 allows up to 96 shallow-well microplates to be dried down at the same time, while capacity for standard 16 x 100mm fraction collector tubes is an outstanding 576 tubes per run.

Benefiting from Genevac’s 20+ years of designing centrifugal evaporators the HT-24 is easy to use, reliable, robust and safe to both operator and sample integrity.

Further aiding productivity the HT-24 includes facility for rapid defrosting, and pull-out sample shelves for easy loading and unloading.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genevac Launches new Information-rich Website
According to Genevac its new website is an information hub for evaporation, concentration and lyophilization.
Tuesday, November 27, 2007
Genevac enhance the HT-12

Thursday, July 04, 2002
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!